Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Feb 28, 2025 | (Q2)Aug 31, 2024 | (Q1)May 31, 2024 | (FY)Feb 29, 2024 | (Q4)Feb 29, 2024 | (Q3)Nov 30, 2023 | (Q2)Aug 31, 2023 | (Q1)May 31, 2023 | (FY)Feb 28, 2023 | (Q4)Feb 28, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -1.35%60.53B | 2.77%12.52B | -3.70%15.38B | 5.29%61.35B | 2.53%16.75B | -0.15%16.45B | 9.69%12.19B | 11.24%15.97B | 50.80%58.27B | 45.95%16.34B |
| Cost of revenue | -2.00%22.72B | 0.56%4.82B | -6.04%5.54B | 4.60%23.18B | 3.05%6.58B | -0.52%5.92B | 7.25%4.79B | 9.92%5.89B | 10.29%22.16B | 1.95%6.38B |
| Gross profit | -0.95%37.81B | 4.21%7.7B | -2.34%9.84B | 5.71%38.17B | 2.20%10.17B | 0.06%10.53B | 11.36%7.39B | 12.03%10.08B | 94.69%36.11B | 101.80%9.95B |
| Operating expense | -0.09%35.09B | 1.83%7.85B | 0.59%9.09B | 3.69%35.12B | 1.22%8.85B | 3.73%9.52B | 3.37%7.71B | 6.47%9.04B | 72.78%33.87B | 82.04%8.75B |
| Operating profit | -10.93%2.72B | 53.46%-148M | -27.90%747M | 36.31%3.05B | 9.27%1.32B | -24.96%1.01B | 61.27%-318M | 105.96%1.04B | 311.34%2.24B | 843.75%1.21B |
| Net non-operating interest income (expenses) | -1.98%-103M | -3.85%-27M | -4.00%-26M | -3.06%-101M | 7.69%-24M | -8.33%-26M | -8.33%-26M | -4.17%-25M | -19.51%-98M | -23.81%-26M |
| Non-operating interest income | --11M | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Non-operating interest expense | 12.87%114M | 3.85%27M | 4.00%26M | 3.06%101M | -7.69%24M | 8.33%26M | 8.33%26M | 4.17%25M | 19.51%98M | 23.81%26M |
| Net investment income | 10.14%239M | -9.96%217M | 31.76%112M | 0 | -12.07%102M | -95.89%3M | 14.76%241M | -6.59%85M | ||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | 1.92B | 0 | -136.73%-184M | |||||||
| Income from associates and other participating interests | 127.27%25M | 100.00%6M | 75.00%14M | 191.67%11M | -150.00%-4M | 4M | 125.00%3M | 200.00%8M | 86.96%-12M | 138.10%8M |
| Special income (charges) | -48.55%-205M | 0 | -56M | 84.72%-138M | 82.58%-138M | 320.00%44M | 58.49%-44M | 0 | -196.47%-903M | -183.54%-792M |
| Less:Other special charges | 202.27%45M | --0 | --20M | -146.32%-44M | --0 | ---- | ---- | ---- | 107.11%95M | 100.92%12M |
| Less:Write off | -12.09%160M | --0 | --36M | -77.48%182M | -82.31%138M | --0 | --44M | --0 | 102.00%808M | 122.22%780M |
| Other non-operating income (expenses) | -554.55%-50M | -200.00%-1M | -225.00%-5M | -83.82%11M | 325.00%9M | -117.65%-3M | -83.33%1M | -91.84%4M | -76.31%68M | -105.97%-4M |
| Income before tax | 48.90%4.53B | 81.56%-52M | -34.34%673M | 125.89%3.05B | 328.28%1.27B | -19.84%1.03B | 66.51%-282M | 68.59%1.03B | 92.57%1.35B | -82.45%297M |
| Income tax | 105.49%524M | 161.54%80M | -35.94%82M | 138.40%255M | 124.23%180M | 30.51%77M | -293.94%-130M | 141.51%128M | -1,847.37%-664M | -7,530.00%-743M |
| Net income | 43.69%4.01B | 11.92%-133M | -34.04%591M | 38.67%2.79B | 5.10%1.09B | -22.41%952M | 81.36%-151M | 61.44%896M | 204.39%2.01B | -38.13%1.04B |
| Net income continuous operations | 43.73%4.01B | 13.16%-132M | -34.11%591M | 38.67%2.79B | 5.00%1.09B | -22.27%953M | 81.21%-152M | 61.62%897M | 203.93%2.01B | -38.17%1.04B |
| Noncontrolling interests | 0.00%2M | 0.00%1M | 0 | 101.41%2M | 100.78%1M | 0 | 125.00%1M | 0 | -142M | -129M |
| Net income attributable to the company | 43.77%4.01B | 12.50%-133M | -34.15%590M | 29.33%2.79B | -6.75%1.09B | -22.66%952M | 81.12%-152M | 60.29%896M | 226.02%2.16B | -30.40%1.17B |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 43.77%4.01B | 12.50%-133M | -34.15%590M | 29.33%2.79B | -6.75%1.09B | -22.66%952M | 81.12%-152M | 60.29%896M | 226.02%2.16B | -30.40%1.17B |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 47.09%351.48 | 12.56%-11.42 | -34.16%50.63 | 33.74%238.96 | -4.12%93.55 | -19.55%81.57 | 80.33%-13.06 | 66.74%76.9 | 227.31%178.68 | -29.70%97.57 |
| Diluted earnings per share | 47.09%351.48 | 12.56%-11.42 | -34.16%50.63 | 39.15%238.96 | -0.28%93.4877 | -19.55%81.57 | 80.33%-13.06 | 73.47%76.9 | 217.25%171.73 | -32.32%93.75 |
| Dividend per share | 46.59%129 | 0 | 0 | 60.00%88 | 60.00%88 | 0 | 0 | 0 | 55 | 55 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |